Collegium Pharmaceutical Inc
NASDAQ:COLL
Collegium Pharmaceutical Inc
NASDAQ:COLL
Price:
33.28
USD
0.64%
Market Cap:
$1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
US |
|
SAGE Therapeutics Inc
NASDAQ:SAGE
|
US |
|
Dantax A/S
CSE:DANT
|
DK |
|
Star Diamond Corp
TSX:DIAM
|
CA |
|
Luks Kadife Ticaret ve Sanayi AS
IST:LUKSK.E
|
TR |
|
SandRidge Energy Inc
NYSE:SD
|
US |
|
Sayona Mining Ltd
ASX:SYA
|
AU |
|
Engie SA
OTC:ENGQF
|
FR |
|
aTyr Pharma Inc
NASDAQ:ATYR
|
US |
|
Neptune Wellness Solutions Inc
TSX:NEPT
|
CA |
|
F
|
Forge Global Holdings Inc
NYSE:FRGE
|
US |
|
Kellton Tech Solutions Ltd
NSE:KELLTONTEC
|
IN |
|
NTPC Ltd
NSE:NTPC
|
IN |
|
Aurizon Holdings Ltd
ASX:AZJ
|
AU |
|
Times China Holdings Ltd
HKEX:1233
|
CN |
|
C
|
Citra Putra Realty Tbk PT
IDX:CLAY
|
ID |
|
FBR Ltd
ASX:FBR
|
AU |
|
V
|
Vulcan Materials Co
DUS:VMC
|
US |
|
B
|
Beijing Jingkelong Co Ltd
HKEX:814
|
CN |
|
Signify NV
AEX:LIGHT
|
NL |
|
Lechwerke AG
F:LEC
|
DE |
|
Shaver Shop Group Ltd
ASX:SSG
|
AU |
|
Queensland Pacific Metals Ltd
ASX:QPM
|
AU |
|
K
|
Kap Industrial Holdings Ltd
JSE:KAP
|
ZA |
Multiples-Based Value
The
Multiples-Based Value for
Collegium Pharmaceutical Inc (COLL)
under the Base Case is
hidden
USD.
Compared with the current market price of 33.28 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
COLL Multiples-Based Value
LOCKED
Multiples Across Competitors
COLL Competitors Multiples
Collegium Pharmaceutical Inc Competitors
Collegium Pharmaceutical Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
1B USD | 1.4 | 16.8 | 3.6 | 8.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 13.9 | 43.9 | 29.6 | 31.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.4 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.9 | 8 | 10.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.6 | 17.7 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
